SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition-Reference-Cited by-同舟云学术

SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition

Published:2020-09 Issue:3 Volume:32 Page:404-419.e6
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Tomita Issei,Kume Shinji,Sugahara Sho,Osawa Norihisa,Yamahara Kosuke,Yasuda-Yamahara Mako,Takeda Naoko,Chin-Kanasaki Masami,Kaneko Tatsuroh,Mayoux Eric,Mark Michael,Yanagita Motoko,Ogita Hisakazu,Araki Shin-ichi,Maegawa Hiroshi

Funder

MSD K.K.

Shiga University of Medical Science

NOVARTIS Foundation (Japan) for the Promotion of Science

Japan Agency for Medical Research and Development

Takeda Medical Research Foundation

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference54 articles.

1. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014;Afkarian;JAMA,2016

2. Pimozide alleviates hyperglycemia in diet-induced obesity by inhibiting skeletal muscle ketone oxidation;Al Batran;Cell Metab.,2020

3. Insulin inhibits lipolysis in adipocytes via the evolutionarily conserved mTORC1-Egr1-ATGL-mediated pathway;Chakrabarti;Mol. Cell. Biol.,2013

4. Salt-responsive metabolite, β-hydroxybutyrate, attenuates hypertension;Chakraborty;Cell Rep.,2018

5. Ketone body signaling mediates intestinal stem cell homeostasis and adaptation to diet;Cheng;Cell,2019

Cited by 232 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care;Biomedicines;2024-09-07

2. SGLT2 inhibitor promotes ketogenesis to improve MASH by suppressing CD8+ T cell activation;Cell Metabolism;2024-09

3. Ketonuria as an Indicator of Improvement of Renal Function in Patients with Type 2 Diabetes Receiving SGLT2 Inhibitor Treatment;Endocrinology and Metabolism;2024-08-31

4. Inhibition of the RXRA-PPARα-FABP4 signaling pathway alleviates vascular cellular aging by an SGLT2 inhibitor in an atherosclerotic mice model;Science China Life Sciences;2024-08-29

5. Impaired ketogenesis in Leydig Cells drives testicular aging;2024-08-09